Tender Details
Title

Darolutamide Medicinal Product as Part of Drug Program B.56 Treatment of Patients with Prostate Cancer Tender Notice International Competitive Bidding

Country
Language
English
Organization
Published Date
16.10.2024
Deadline Date
24.10.2024
Overview
Darolutamide Medicinal Product as Part of Drug Program B.56 Treatment of Patients with Prostate Cancer SECTION II - BASIC INFORMATION 2.1.) The announcement concerns: Public procurement 2.2.) The announcement concerns social services and other specific services: No 2.3.) Name of the order or framework agreement: Darolutamide medicinal product under the B.56 Drug Program Treatment of patients with prostate cancer UNIVERSITY CLINICAL HOSPITAL IN POZNAN Ul. Stanislawa Przybyszewskiego 49, Poznan, 60-355, Greater Poland, Poland dzp@usk.poznan.pl Tender Notice International Competitive Bidding Poland GT-108705218
NAICS
Justice Justice Other Justice Colleges Colleges International Colleges Other Justice
CPVS
Sections Other services
UNSPSC
Drug cases Case making services University Financial Instruments, Products, Contracts and Agreements
Regions
Eastern Europe Europe
Sectors
Healthcare and Medicine Roads and Highways-Bridge Law and Legal Printing and Publishing Services Cement and Asbestos Products Defence and Security Construction Agriculture-Food and Beverages Energy-Power and Electrical Computer Hardwares and Consumables Construction Materials
URL
Share
To be notified
when a tender matching your filter is published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert